Lipid deposition in parenteral infusion lines.
D002118:Calcium / Q000009:adverse effects*; D004344:Drug Incompatibility; D004868:Equipment Failure; D005217:Fat Emulsions, Intravenous / Q000378:metabolism*; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D010289:Parenteral Nutrition, Total; D011247:Pregnancy
D005217:Fat Emulsions, Intravenous; D006493:Heparin; D002118:Calcium